Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical transplantation

BACKGROUND: Donor‐specific anti‐human leukocyte antigen (HLA) antibodies (DSAs) in recipients is a risk factor for donor stem cell graft failure in haploidentical hematopoietic stem cell transplantation (haplo‐HSCT), and the treatment to reduce the levels of DSAs is not unanimous. This study was to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Lab Anal
Main Authors: Zhang, Rongli, He, Yi, Yang, Donglin, Jiang, Erlie, Ma, Qiaoling, Pang, Aiming, Zhai, Weihua, Wei, Jialin, Feng, Sizhou, Han, Mingzhe
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370703/
https://ncbi.nlm.nih.gov/pubmed/32112480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados